From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access

• Главные авторы: Peter J. Hotez (Автор), Rakesh Adhikari (Автор), Wen-Hsiang Chen (Автор), Yi-Lin Chen (Автор), Portia Gillespie (Автор), Nelufa Y. Islam (Автор), Brian Keegan (Автор), Rakhi Tyagi Kundu (Автор), Jungsoon Lee (Автор), Zhuyun Liu (Автор), Jason T. Kimata (Автор), Numan Oezguen (Автор), Jeroen Pollet (Автор), Cristina Poveda (Автор), Kay Razavi (Автор), Shannon E. Ronca (Автор), Ulrich Strych (Автор), Syamala R. Thimmiraju (Автор), Leroy Versteeg (Автор), Maria Jose Villar-Mondragon (Автор), Junfei Wei (Автор), Bin Zhan (Автор), Maria Elena Bottazzi (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Introduction The development of a yeast-expressed recombinant protein-based vaccine technology co-developed with LMIC vaccine producers and suitable as a COVID-19 vaccine for global access is described. The proof-of-concept for developing a SARS-CoV-2 spike protein receptor-binding domain (RBD) anti...